- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Phalanges.
Displaying page 1 of 1.
EudraCT Number: 2004-002832-24 | Sponsor Protocol Number: CZOL446GDE21 | Start Date*: 2005-07-27 |
Sponsor Name:Novartis Pharma GmbH | ||
Full Title: Influence of Zoledronic acid (Zometa®) on bone mineral density and bone ultrasonometry in premenopausal women with hormone receptor positive breast cancer and neoadjuvant or adjuvant chemoendocrine... | ||
Medical condition: Hormonreceptor positive breast cancer in premenopausal women | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002831-14 | Sponsor Protocol Number: CZOL446GDE13 | Start Date*: 2005-06-09 |
Sponsor Name:Novartis Pharma GmbH | ||
Full Title: Influence of Zoledronic acid (Zometa®) on bone mineral density and bone ultrasonometry in premenopausal women with hormone receptor negative breast cancer and adjuvant chemotherapeutic treatment | ||
Medical condition: Primary, hormonreceptor negative breast cancer in premenopausal women | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004254-22 | Sponsor Protocol Number: PASTOR2018 | Start Date*: 2020-03-20 | ||||||||||||||||
Sponsor Name:Charite University | ||||||||||||||||||
Full Title: Efficacy of Tofacitinib in Reduction of Inflammation Detected on MRI in Patients with Psoriatic ArthritiS PresenTing with Axial InvOlvement - a Randomized, Double-Blind, Placebo-Controlled, Mult... | ||||||||||||||||||
Medical condition: Psoriatic Arthritis with axial (spinal) involvement | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000874-92 | Sponsor Protocol Number: LUM-201-01 | Start Date*: 2021-03-22 | |||||||||||
Sponsor Name:Lumos Pharma, Inc. | |||||||||||||
Full Title: A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children with Idiopathic Growth Hormone Deficie... | |||||||||||||
Medical condition: Growth hormone deficiency | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
